Data shows majority of Australian sites are open for clinical trial activity
Focus:
Most Read
- Data shows majority of Australian sites are open for clinical trial activity
- Managing the Covid-19 outbreak: Lessons learnt from South Korea
- Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial
- Case studies in accelerating clinical trials in oncology
- Regulatory requirements for clinical trials: A comparison of Australia and the US
Latest Content
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral infections.
Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial
The alliance of regional specialists can provide the best of all worlds: global coverage, regional specialisation and mid-sized CRO flexibility.
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years.
Regulatory requirements for clinical trials: A comparison of Australia and the US
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast and pragmatic regulatory pathway for early phase clinical trials.
Latest News
Close
Close
Close
Go Top